There are 2949 resources available
Optimising clinical outcomes: the case for personalised medicine in ovarian cancer
Presenter: Ignace Vergote
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Panel discussion
Presenter: Ignace Vergote
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Summary and meeting close
Presenter: Ana Oaknin
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Targeting the HER pathway in other tumors: An evolving paradigm
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Emerging HER2-directed therapies in gastric and colorectal cancer
Presenter: Kohei Shitara
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Evolving approaches in targeting HER2 in advanced NSCLC
Presenter: Egbert Smit
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Live Q&A - 28 September 2020 - 15:30-16:00
Presenter: Cristina Suarez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Introduction
Presenter: Giuseppe Curigliano
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
Introduction to RET mutations and fusions and their incidence for potential use as target in cancer treatment
Presenter: Alexander Drilon
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
RET fusion TKI: Present results and recent developments in Lung cancer
Presenter: David Planchard
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast